Novo Integrated Sciences

NVOS · OTC

$0.0006−$0.0014 (−70.00%)TodayMarket closed · Oct 20, 3:34 PM ET

No price history for this range.

About NVOS

Novo Integrated Sciences, Inc. engages in the provision of medical services. The company is headquartered in Bellevue, Washington and currently employs 115 full-time employees. The company went IPO on 2005-07-12. The company operates through two reportable segments: healthcare services and product sales. Its businesses include healthcare, medical technology, manufacturing, research and diagnostics, and products and brands. Its specialized primary health care services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, and others. Its products include Terragenx and ProDip (dietary supplement pouches). Terragenx is a micro-dosing IoNovo Iodine product for all ages and lifestyles. Its medical technologies include telemedicine, and remote patient monitoring.

Employees: 115
Headquarters: Bellevue, Washington
Listed: Jul 12, 2005
Sector: Health Care
Industry: Health Care Providers & Services
Website: novointegrated.com

Leadership

Novo Integrated Sciences executives
Name	Title	Since	Age
Robert Mattacchione	—	2018	56
Vivek Sethi	—	—	38
Christopher David	—	2014	65
Robert Oliva	—	2021	60
Sarfaraz Ali	—	—	43
Alex Flesias	—	—	50

Revenue by product and region

Fiscal year ended Aug 31, 2024: $13.29M total revenue

By product

Healthcare Services [Member]$8.30M62.4%
Product Sales [Member]$4.92M37.0%
Corporate Segment [Member]$78.25K0.6%

Similar companies

Companies in the same industry as Novo Integrated Sciences

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.